(12) Patent Application Publication (10) Pub. No.: US 2003/0054021 A1 Dalko Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2003/0054021 A1 Dalko Et Al US 20030054021A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0054021 A1 Dalko et al. (43) Pub. Date: Mar. 20, 2003 (54) 7-OXO-DHEACOMPOUNDS FOR TREATING (30) Foreign Application Priority Data KERATINOUS CONDITIONS/AFFLICTIONS Jun. 14, 2001 (FR)............................................ 01/07804 (76) Inventors: Maria Dalko, Gif Sur Yvette (FR); Publication Classification Alexandre Cavezza, Tremblay-En-France (FR); Elisabeth (51) Int. Cl." ....................... A61K 31/695; A61K 31/66; Picard-Lesboueyries, Velizy (FR); A61K 31/58; A61K 31/56; Beatrice Renault, Saint Maurice (FR); A61K 7/OO Veronique Burnier, Paris (FR) (52) U.S. Cl. ............................ 424/401; 514/63; 514/172; 514/176; 514/177; 514/143 Correspondence Address: (57) ABSTRACT Norman H. Stepno, Esquire BURNS, DOANE, SWECKER & MATHIS, 7-Oxo-DHEA derivatives, various of which are themselves L.L.P. novel compounds, are well Suited for cosmetically/therapeu P.O. Box 1404 tically treating adverse conditions/afflictions of a keratinous Alexandria, VA 22313-1404 (US) Substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat Signs of aging of the Skin and/or a dull (21) Appl. No.: 10/170,679 complexion and/or skin or hair pigmentation disorders and/ or dryneSS of the skin and/or hyperSeborrhoea and/or hyper Seborrhoea-related imperfections and/or Sensitive skin and/ (22) Filed: Jun. 14, 2002 or dandruff and/or natural hair loSS and/or baldness. US 2003/0054021 A1 Mar. 20, 2003 7-OXO-DHEACOMPOUNDS FOR TREATING KERATINOUS CONDITIONS/AFFLICTIONS (I) Me O CROSS-REFERENCE TO PRIORITY APPLICATION Me 0001. This application claims priority under 35 U.S.C. S 119 of FR-01/07804, filed Jun. 14, 2001, hereby expressly incorporated by reference. R No O BACKGROUND OF THE INVENTION 0010. Among these compounds, 3 B-acetoxy-7-oxo 0002) 1. Technical Field of the Invention DHEA or A5-androstene-3,3-acetoxy-7,17-dione is already 0003. The present invention relates to novel 7-oxo known and has been described as being effective in modu DHEA derivatives, to a process for Synthesizing Such novel lating the immune system (U.S. Pat. Nos. 5,292,730, 5,585, compounds and to cosmetic/therapeutic compositions com 371 and 5,641,766), treating Alzheimer's disease (U.S. Pat. prising Same. No. 5,707,983), treating HIV syndrome (U.S. Pat. No. 5,885,977) and for promoting weight loss (U.S. Pat. Nos. 0004. The present invention also relates to cosmetic 5,296,481 and 5,807,848). applications of at least one 7-oxo-DHEA derivative to 0011 WO-99/25333 also indicates the administration, improve the appearance of keratin materials and Substrates, especially topically, of 3,3-acetoxy-7-oxo-DHEA in the pro Such as the skin, the hair, the eyelashes and the nails, in phylactic and curative treatment of lupus erythematosus, particular to prevent or treat adverse signs of aging of the which is a disorder of the immune system that is liable to skin and/or a dull complexion and/or skin or hair pigmen affect Several organs and that is manifested in the skin by tation disorders and/or dryness of the skin and/or hyperse transverse redness of the face and/or by Squamous erythemal borrhoea and/or hyperSeborrhoea-related imperfections and/ plaques disseminated over the body. or Sensitive Skin and/or dandruff and/or natural hair loSS 0012 U.S. Pat. No. 5,424,463 especially describes and/or baldness. 7-keto-DHEA (or A5-androstene-3B-ol-7,17-dione) and 0005. This invention also relates to a cosmetic regime/ derivatives thereof wherein one or more of the hydroxyl or regimen for treating keratinous Substrates/materials by topi keto Substituents is a group convertible thereto by hydroly cal application thereon of a composition containing at least Sis. Hydrolyzable groups include hydroxyl groups esterified one 7-oxo-DHEA derivative, formulated into a physiologi with an acid selected from the group consisting of (i) a cally acceptable medium therefor. normal, branched, Saturated or unsaturated C-C aliphatic acid, (ii) a C7-C aromatic acid, (iii) a C- or more dicar 0006 2. Description of the Prior Art boxylic acid, for which only one carbonyl group is esterified with the 3-hydroxy group of the Steroid, (iv) an inorganic 0007 DHEA, or dehydroepiandrosterone, is a natural acid such as Sulfuric acid and phosphoric acid. U.S. Pat. No. Steroid produced essentially by the adrenal glands. EXOg 5,424,463 describes the 7-keto- and hydrolyzable deriva enous DHEA, administered topically or orally, is recognized tives thereof as being effective for promoting weight loSS. for its capacity to promote epidermal keratinization (JP-07, 0013 In addition, the following derivatives are also 196,467) and to treat dry skin by increasing the endogenous described as being effective for promoting weight loSS production and Secretion of Sebum and thus by reinforcing (Steroids, 1998, 63(3), pp. 158-165): 3 B-O-acetyl-7-oxo the skin's barrier effect (U.S. Pat. No. 4,496.556). U.S. Pat. dehydroepiandrosterone (or 3,3-acetyl-7-oxo-DHEA); No. 5,843,932 has also described the administration of 3|8-O-propionyl-7-oxo-dehydroepiandrosterone (or 3 B-pro DHEA to remedy dermal atrophy by inhibiting the loss of pionyl-7-oxo-DHEA); 3.3-O-butanoyl-7-oxo-dehydroepi collagen and of connective tissue. Too, the assignee hereof androsterone (or 3,3-butanoyl-7-oxo-DHEA); 3 B-O-isobu has demonstrated the capacity of DHEA to combat the tanoyl-7-oxo-dehydroepiandrosterone; 3 B-O-heptanoyl-7- weathered appearance of the skin (FR-00/00349), to modify OXO-dehydroepiandrosterone; 3f6-O-dodecanoyl-7-oxo skin and hair pigmentation (FR-99/12773) and to combat dehydroepiandrosterone; 3f6-O-palmitoyl-7-oxo epidermal atrophy (FR-00/06154). These properties of dehydroepiandrosterone; 3f6-O-stearoyl-7-oxo DHEA make it a candidate of choice as an anti-aging active dehydroepiandrosterone; 3.3-O-hemisuccinate-7-oxo agent. dehydroepiandrosterone. 0008. However, DHEA has hormonal effects that may 0014) Among the 7-oxo-DHEA derivatives of formula (I) prove difficult as regards the administration of Same. There that are described in the prior art are the following deriva need Still exists to provide DHEA analogs with properties as tives: advantageous as DHEA itself, but without eliciting any 0.015 (1) The derivative of formula (I) in which R is hormonal effects. a 2-tetrahydropyran group (RN 102 890-86-8). 0009. It was first considered by applicants that the 7-oxo 0016 (2) The compound of formula (I) in which R DHEA derivatives of general formula (I) below could satisfy is a CHOCO group, described as Suppressing the this need: transactivation of the androgenic receptor induced US 2003/0054021 A1 Mar. 20, 2003 by an androstenediol in human prostate cancer cells and/or Sulfate and/or phosphate and/or aryl and/or hetero (Proc. Natl. Acad. Sci. USA, 1999, 96(20), pp. cycle, Said heterocycle advantageously being an indole, a 11173-11177). pyrimidine, a piperidine, a morpholine, a pyran, a furan, a piperazine or a pyridine, an alkylcarbonyl radical, with the 0017 (3) Derivatives of formula (I) in which R is an exception of the CH-CO-radical, the C-C alkyl moiety of O=P(OH)OCOCH group or a group which is Saturated or unsaturated, linear or branched, or cyclic, and optionally Substituted with one or more Substitu CO2H ents selected from among -OR" and/or - SR" and/or -COOR" and/or -NR'R' and/or halogen and/or sulfate and/or phosphate and/or aryl and/or heterocycle, Said het erocycle advantageously being an indole, a pyrimidine, a piperidine, a morpholine, a pyran, a furan, a piperazine or a pyridine, an arylcarbonyl radical, preferably a phenylcarbo nyl radical, or an arylalkylcarbonyl radical, preferably a benzylcarbonyl radical, optionally Substituted with one or more of the Substituents -OR" and/or -SR' and/or COOR and/or -NR'R' and/or halogen and/or aryl and/or hetero cycle; a group O=P(OH)OR'; a group (O)SOR"; a trialkyl 0018) described in U.S. Pat. No. 5,837,269 as silyl radical (SiR') in which the 3 groups R' may be identical agents for increasing the immune response to a or different; an alkyloxycarbonyl group (R'OCO); an alky Vaccine. laminocarbonyl group (R'NHCO); wherein R' is a hydrogen 0.019 (4) The derivative of formula (I) in which R is atom, a Saturated or unsaturated, linear or branched, or a group molPhCO, described in an epoxidation cyclic C-C and preferably C-C alkyl radical, which may process for the synthesis of steroids (J. Chem. Soc. optionally contain one or more hetero atoms, optionally Perkin Trans. I, 1975 (4), pp. 323-6). functionalized with one or more of the groups -OR", -COOR", halogen, -NR"R", or with an aryl group, pref 0020 (5) Derivatives of formula (I) in which R is an erably a phenyl group, optionally functionalized with one or NaSOH group or an SOH group, noted in Endo more of the groups -OR", -COOR", halogen or crinol. Exp., 1971, 5(4), pp. 205-210, which -NR"R", and preferably wherein R' is a hydrogen atom, a describes the properties of these derivatives when methyl, an ethyl, a butyl, a propyl or an isopropyl radical; they are subjected to various hydrolysis conditions. and R" is a hydrogen atom or a Saturated or unsaturated, linear or branched or cyclic alkyl radical, preferably C-C, 0021 (6) The derivative of formula (I) in which R is preferably R" is a hydrogen atom, a methyl, an ethyl, abutyl, a tEuSi(Me) group, described in a steroid prepara a propyl or an isopropyl radical; with the proviso that, in tion process (Heterocycles, 1994, 38(5), pp.
Recommended publications
  • Chapter 6—Clove Oil (Eugenol)
    Chapter 6—Clove Oil (Eugenol) OH CH3 O Eugenol Chapter 6: Clove oil 6-2 6 Table of Contents — Clove Oil (Eugenol) 6.1 INTRODUCTION ......................................................................................................................................... 6-4 6.2 CLOVE OIL AND EUGENOL TOXICITY TO HUMANS AND LEVELS OF CONCERN ................ 6-6 6.2.1 HEALTH EFFECTS ...................................................................................................................................... 6-7 6.2.1.A Acute Effects—Sensitization ........................................................................................................... 6-7 6.2.1.B Acute Effects—Skin, Eyes and Respiratory System ........................................................................ 6-7 6.2.1.C Acute Effects—Systemic Poisoning ................................................................................................ 6-7 6.2.1.D Effects in Human Cells .................................................................................................................... 6-8 6.2.1.E Levels of Concern for Humans ........................................................................................................ 6-8 6.2.2 PESTICIDE ILLNESS REPORTS .................................................................................................................... 6-9 6.3 EUGENOL TOXICITY TO ANIMALS AND PLANTS AND LEVELS OF CONCERN .................... 6-10 6.3.1 MAMMALS .............................................................................................................................................
    [Show full text]
  • Understanding and Managing the Transition Using Essential Oils Vs
    MENOPAUSE: UNDERSTANDING AND MANAGING THE TRANSITION USING ESSENTIAL OILS VS. TRADITIONAL ALLOPATHIC MEDICINE by Melissa A. Clanton A thesis submitted in partial fulfillment of the requirements for the Diploma of Aromatherapy 401 Australasian College of Health Sciences Instructors: Dorene Petersen, Erica Petersen, E. Joy Bowles, Marcangelo Puccio, Janet Bennion, Judika Illes, and Julie Gatti TABLE OF CONTENTS List of Tables and Figures............................................................................ iv Acknowledgments........................................................................................ v Introduction.................................................................................................. 1 Chapter 1 – Female Reproduction 1a – The Female Reproductive System............................................. 4 1b - The Female Hormones.............................................................. 9 1c – The Menstrual Cycle and Pregnancy....................................... 12 Chapter 2 – Physiology of Menopause 2a – What is Menopause? .............................................................. 16 2b - Physiological Changes of Menopause ..................................... 20 2c – Symptoms of Menopause ....................................................... 23 Chapter 3 – Allopathic Approaches To Menopausal Symptoms 3a –Diagnosis and Common Medical Treatments........................... 27 3b – Side Effects and Risks of Hormone Replacement Therapy ...... 32 3c – Retail Cost of Common Hormone Replacement
    [Show full text]
  • The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol
    molecules Article The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol, and Terpineol on Escherichia coli Biofilm Control as Assessed by Culture-Dependent and -Independent Methods Magdalena A. Olszewska 1,* , Astrid G˛edas 1 and Manuel Simões 2,* 1 Department of Industrial and Food Microbiology, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Plac Cieszy´nski1, 10-726 Olsztyn, Poland; [email protected] 2 LEPABE–Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.A.O.); [email protected] (M.S.); Tel.: +48-89-5233729 (M.A.O.); +351-22508-1654 (M.S.); Fax: +351-22508-1449 (M.S.) Received: 14 May 2020; Accepted: 5 June 2020; Published: 6 June 2020 Abstract: Bacterial biofilms contribute to problems with preserving food hygiene, jeopardizing any conventional intervention method used by the food industry. Hence, the approach of using essential oil (EO) compounds effective in biofilm control has considerable merit and deserves in-depth research. In this study, the effect of selected EO compounds (eugenol, trans-cinnamaldehyde, citronellol, and terpineol) was assessed on Escherichia coli biofilm control by plate count, resazurin assay, and Syto® 9/PI (-/propidium iodide) staining coupled with flow cytometry (FCM) and confocal laser scanning microscopy (CLSM). The selected EO compounds effectively inhibited the growth of planktonic E. coli at low concentrations of 3–5 mM, revealing a high antimicrobial activity. EO compounds markedly interfered with biofilms too, with trans-cinnamaldehyde causing the most prominent effects. Its antibiofilm activity was manifested by a high reduction of cell metabolic activity (>60%) and almost complete reduction in biofilm cell culturability.
    [Show full text]
  • The Synthesis of Vanillin
    The synthesis of vanillin - learning about aspects of sustainable chemistry by comparing different syntheses La síntesis de la vainilla - aprendiendo sobre aspectos de química sostenible mediante la comparación de diferentes síntesis NICOLE GARNER1, ANTJE SIOL2 , INGO EILKS1 1 Institute for Science Education, University of Bremen, 2 Center for Environmental Research and Sustainable Technology, University of Bremen, Germany, [email protected] Abstract • Prevention This paper discusses one way of integrating the aspects of sustainable chemistry into • Atom Economy secondary and undergraduate chemistry education. Two different synthesis reactions • Less Hazardous Chemical Syntheses for vanillin are presented, which both use isoeugenol as the starting reagent. Whereas • Designing Safer Chemicals the first synthesis is performed using conventional chemistry techniques, second • Safer Solvents and Auxiliaries approach employs strategies inspired by sustainable chemistry. The discussion • Design for Energy Efficiency covers how comparison of these two experiments can aid in learning about selected • Use of Renewable Feedstocks sustainable chemistry principles. • Reduce Derivatives Key words: education for sustainable development, chemistry education, green • Catalysis chemistry, vanillin • Design for Degradation • Real-time Analysis for Pollution Prevention Resumen • Inherently Safer Chemistry for Accident Prevention Este artículo analiza una manera de integrar los aspectos de la química sostenible en la escuela secundaria y en bachillerato.
    [Show full text]
  • Electroanalysis May Be Used in the Vanillin Biotechnological Production
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Open Archive Toulouse Archive Ouverte OATAO is an open access repository that collects the work of Toulouse researchers and makes it freely available over the web where possible This is an author’s version published in: http://oatao.univ-toulouse.fr/20317 Official URL: https://doi.org/10.1007/s12010-013-0631-2 To cite this version: Giraud, William and Mirabel, Marie and Comtat, Maurice Electroanalysis may be used in the Vanillin Biotechnological Production. (2014) Applied Chemistry and Biotechnology, 172 (4). 1953-1963. ISSN 0273-2289 Any correspondence concerning this service should be sent to the repository administrator: [email protected] Electroanalysis may be used in the Vanillin Biotechnological Production William Giraud & Marie Mirabel & Maurice Comtat Abstract This study shows that electroanalysis may be used in vanillin biotechnological production. As a matter of fact, vanillin and some molecules implicated in the process like eugenol, ferulic acid, and vanillic acid may be oxidized on electrodes made of different materials (gold, platinum, glassy carbon). By a judicious choice of the electrochemical method and the experimental conditions the current intensity is directly proportional to the molecule concentrations in a range suitable for the biotechnological process. So, it is possible to imagine some analytical strategies to control some steps in the vanillin biotechnological production: by sampling in the batch reactor during the process, it is possible to determine out of line the concentration of vanillin, eugenol, ferulic acid, and vanillic acid with a gold rotating disk electrode, and low concentration of vanillin with addition of hydrazine at an amalgamated electrode.
    [Show full text]
  • Identification of Flavour Additives in Tobacco Products to Develop A
    Research paper Tob Control: first published as 10.1136/tobaccocontrol-2016-052961 on 11 February 2017. Downloaded from Identification of flavour additives in tobacco products to develop a flavour library Erna JZ Krüsemann, Wouter F Visser, Johannes WJM Cremers, Jeroen LA Pennings, Reinskje Talhout ► Additional material is ABStract flavoured tobacco products over unflavoured 2 published online only. To view Objectives This study combines chemical analysis products. Furthermore, Kreslake and colleagues please visit the journal online (http:// dx. doi. org/ 10. 1136/ and flavour descriptions of flavour additives used in analysed data from tobacco industry documents, tobaccocontrol- 2016- 052961). tobacco products, and provides a starting point to build which show that tobacco companies use strat- an extensive library of flavour components, useful for egies to manipulate sensory characteristics of National Institute for Public product surveillance. cigarettes, for instance the menthol content, to Health and the Environment Methods Headspace gas chromatography-mass facilitate smoking initiation.3 According to them, (RIVM), Bilthoven, The Netherlands spectrometry (GC-MS) was used to compare 22 this strategy has been most successful in attracting commercially available tobacco products (cigarettes youth and young adult smokers. Correspondence to and roll-your-own) expected to have a characterising Overall, tobacco products with a characterising Professor Reinskje Talhout, flavour and 6 commercially available products not flavour stimulate young people to initiate smoking National Institute for Public expected to have a characterising flavour with 5 and therefore contribute to an increased use of Health and the Environment reference products (natural tobacco leaves and research 1 4 (RIVM), Antonie van tobacco products. Leeuwenhoeklaan 9, 3721 MA cigarettes containing no flavour additives).
    [Show full text]
  • Bio-Based Thermosetting Copolymers of Eugenol and Tung Oil Harris Handoko Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2014 Bio-based thermosetting copolymers of eugenol and tung oil Harris Handoko Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Mechanics of Materials Commons, and the Polymer Chemistry Commons Recommended Citation Handoko, Harris, "Bio-based thermosetting copolymers of eugenol and tung oil" (2014). Graduate Theses and Dissertations. 13757. https://lib.dr.iastate.edu/etd/13757 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Bio-based thermosetting copolymers of eugenol and tung oil by Harris Handoko A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Material Science and Engineering Program of Study Committee: Samy Madbouly, Co-Major Professor Lawrence Genalo, Co-Major Professor Xiaoli Tan David Grewell Iowa State University Ames, Iowa 2014 Copyright © Harris Handoko, 2014. All rights reserved. ii TABLE OF CONTENTS LIST OF ABBREVIATIONS………………………………………………………………...... iv ACKNOWLEDGEMENT…………………………………………………………………..… vi ABSTRACT…………………………………………………………………………………..... vii CHAPTER 1: BACKGROUND INFORMATION 1.1
    [Show full text]
  • Method of Preparing Vanillin
    (19) TZZ¥Z_T (11) EP 3 045 444 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC (43) Date of publication: (51) Int Cl.: 20.07.2016 Bulletin 2016/29 C07C 47/58 (2006.01) (21) Application number: 15750614.8 (86) International application number: PCT/CN2015/085408 (22) Date of filing: 29.07.2015 (87) International publication number: WO 2016/000664 (07.01.2016 Gazette 2016/01) (84) Designated Contracting States: • LIU, Zhenjiang AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Jiaxing City, Zhejiang 314000 (CN) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • YAO, Yueliang PL PT RO RS SE SI SK SM TR Jiaxing City, Zhejiang 314000 (CN) Designated Extension States: • WANG, Chaoyang BA ME Jiaxing City, Zhejiang 314000 (CN) Designated Validation States: • WU, Jianxin MA Jiaxing City, Zhejiang 314000 (CN) • ZHAO, Feifei (30) Priority: 30.06.2014 CN 201410304472 Jiaxing City, Zhejiang 314000 (CN) (71) Applicant: JIAXING ZHONGHUA CHEMICAL CO., (74) Representative: Johnson, Richard Alan et al LTD. Mewburn Ellis LLP Nanhu District City Tower Jiaxing City, 40 Basinghall Street Zhejiang 314000 (CN) London EC2V 5DE (GB) (72) Inventors: Remarks: • MAO, Haifang A request for restoration of the right of priority under Jiaxing City, Zhejiang 314000 (CN) Rule 49ter.2 PCT is pending before the EPO as • WANG, Lizhi designated Office. Jiaxing City, Zhejiang 314000 (CN) (54) METHOD OF PREPARING VANILLIN (57) A method of preparing vanillin comprises weigh- water with the volume ratio of water to the first solvent ing eugenol, a strong alkali,
    [Show full text]
  • Eugenol—The Active Principle from Cloves Inhibits 5-Lipoxygenase Activity and Leukotriene-C4 in Human PMNL Cells
    ARTICLE IN PRESS Prostaglandins, Leukotrienes and Essential Fatty Acids 74 (2006) 23–27 www.elsevier.com/locate/plefa Eugenol—The active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells H. Raghavenraa, B.T. Diwakra, B.R. Lokeshb, K.A. Naidua,Ã aDepartment of Biochemistry and Nutrition, Central Food Technological Research Institute, Cheluvamba Mansion, Mysore, Karnataka 570 020, India bLipid Science and Traditional Foods, Mysore, Karnataka, India Received 30 June 2005; received in revised form 11 July 2005; accepted 11 August 2005 Abstract Polymorphonuclear leukocytes (PMNL) play an important role in the modulation of inflammatory conditions in humans. PMNL cells recruited at the site of inflammation, release inflammatory mediators such as leukotrienes, proteolytic enzymes and reactive oxygen species. Among these, leukotrienes are implicated in pathophysiology of allergic and inflammatory disorders like asthma, allergic rhinitis, arthritis, inflammatory bowel disease and psoriasis. 5-Lipoxygenase (5-LO) is the key enzyme in biosynthetic pathway of leukotrienes. Our earlier studies showed that spice phenolic active principles significantly inhibit 5-LO enzyme in human PMNLs. In this study we have further characterized the inhibitory mechanism of eugenol, the active principle of spice-clove on 5-LO enzyme and also its effect on leukotriene C4 (LTC4). Substrate dependent enzyme kinetics showed that the inhibitory effect of eugenol on 5-LO was of a non-competitive nature. Further, eugenol was found to significantly inhibit the formation of LTC4 in calcium ionophore A23187 and arachidonic acid (AA) stimulated PMNL cells. These data clearly suggest that eugenol inhibits 5-LO by non-competitive mechanism and also inhibits formation of LTC4 in human PMNL cells and thus may have beneficial role in modulating 5-LO pathway in human PMNL cells.
    [Show full text]
  • Efficacy of Benzocaine, Eugenol, and Menthol As Anesthetics for Freshwater Angelfish
    Journal of Aquatic Animal Health 30:210–216, 2018 © 2018 American Fisheries Society ISSN: 0899-7659 print / 1548-8667 online DOI: 10.1002/aah.10030 ARTICLE Efficacy of Benzocaine, Eugenol, and Menthol as Anesthetics for Freshwater Angelfish Rafael de Souza Romaneli, Andre Zuffo Boaratti, Andressa Tellechea Rodrigues, Daniel Monge de Almeida Queiroz, Kifayat Ullah Khan, Thiago Matias Torres Nascimento, and Joao~ Batista Kochenborger Fernandes Aquaculture Center, Sao~ Paulo State University, Via de Acesso Paulo Donato Castellane s/n, 14884-900 Jaboticabal, Sao~ Paulo, Brazil Cleber Fernando Menegasso Mansano* Campus Fernandopolis, Brazil University, Estrada Projetada F-1, s/n Fazenda Santa Rita, 15600-000 Fernandopolis, Sao~ Paulo, Brazil Abstract For the production and commercialization of ornamental fish species, it is indispensable to collect biometric data that facilitate the selection of animals for trade and genetic improvement of the stock. However, during the handling process, fish receive more stress if proper anesthetics are not used. Thus, application of appropriate anesthetics is an important tool for minimizing stress in animals. The objective of this study was to determine the effective concentra- tions of benzocaine, eugenol, and menthol for achieving anesthesia in Freshwater Angelfish Pterophyllum scalare and to develop induction and recovery response curves for different concentrations of these anesthetics. In total, 75 fish were exposed to five concentrations of the three anesthetics in a completely randomized design: benzocaine at 60, 85, 110, 135, and 160 mg/L; eugenol at 40, 80, 120, 160, and 200 mg/L; and menthol at 50, 75, 150, 200, and 250 mg/L. Each concentration (5 fish/concentration) consisted of five replicates, with each replicate represented by a single fish.
    [Show full text]
  • Caryophylli-Aetheroleum-Summary-Report-Committee-Veterinary-Medicinal-Products En.Pdf
    The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/MRL/406/98-FINAL May 1998 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS CARYOPHYLLI AETHEROLEUM SUMMARY REPORT 1. Caryophylli aetheroleum is the volatile oil of the flower buds of Syzygium aromaticum (L.) Merr. & Perry (synonym: cloves), which contain 15 to 18% of the oil. The oil contains: eugenol (80 to 90%), eugenyl acetate (2 to 27%), ß-caryophyllene (5 to 12%), methyl salicylate, methyl eugenol, benzaldehyde, methyl amyl keton and a-ylangene. 2. Caryophylli aetheroleum is contained in two veterinary medicinal combination products containing 9 and 6 other active ingredients, respectively. The concentration of Caryophylli aetheroleum in the first product is 0.008%. It is administered as a nose-spray to newborn of all food producing species as a respiratory stimulant. The dose ranges from 0.1 g to 0.3 g, depending on body weight. The maximum single dose of Caryophylli aetheroleum is 0.024 mg. The treatment may be repeated after 10 to 15 seconds. In the other product, Caryophylli aetheroleum is contained in a concentration of 0.5%. The oinment is used for disinfection of the udder and to prevent transmission of diseases of the udder of cattle, horses, goats, sheep, and pigs. The ointment is used as frequently as is required. Caryophylli aetheroleum is traditionally used orally in human medicine as a carminative, and occasionally for the treatment of flatulent colic, and topically for symptomatic relief of toothache. The doses used are 0.05 to 0.2 ml. Cloves, which contain Caryophylli aetheroleum, are used as a spice and for flavouring of food.
    [Show full text]
  • The Composition, Structure, Sources, and Applications of Eugenol
    ESSAI Volume 12 Article 19 Spring 2014 The ompC osition, Structure, Sources, and Applications of Eugenol Frank Giuliani College of DuPage Follow this and additional works at: http://dc.cod.edu/essai Recommended Citation Giuliani, Frank (2014) "The ompositC ion, Structure, Sources, and Applications of Eugenol," ESSAI: Vol. 12, Article 19. Available at: http://dc.cod.edu/essai/vol12/iss1/19 This Selection is brought to you for free and open access by the College Publications at DigitalCommons@COD. It has been accepted for inclusion in ESSAI by an authorized administrator of DigitalCommons@COD. For more information, please contact [email protected]. Giuliani: The Composition, Structure, Sources The Composition, Structure, Sources, and Applications of Eugenol by Frank R. Giuliani (Honors Chemistry 1552) hat do cloves, cinnamon, nutmeg, essential oil, which is said to have the and basil have in common? Maybe “essence” of the plant that gives it its taste and W you recognize each of them as smell. For instance, the essence of cloves can common culinary herbs, which they are, but be generally extracted using an organic there is actually a characteristic molecule that solvent such as olive oil which will dissolve is found to some extent in each, referred to as some of the eugenol in the plant matter [3]. eugenol. Eugenol is an organic molecule This would work given the principle of like consisting of a six carbon ring of alternating molecules dissolving like molecules. The double-bonds; two oxygen atoms are singly- smaller the plant can be broken up the better, bonded to carbons in the ring, one of the which increases the surface area of the oxygen atoms is single-bonded to another particles being dissolved.
    [Show full text]